Metabolic syndrome (MetS) is a multifaceted disease characterized by impaired insulin metabolism and glucose tolerance, obesity in the abdominal area, dyslipidemia, and hypertension [1]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.